Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism

NCT00571324 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Congenital Hyperinsulinism

Interventions

DRUG: Exendin-(9-39)
OTHER: Vehicle

Sponsor

Diva De Leon

Collaborators

[object Object]
[object Object]